Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dendritic cells are professional antigen-presenting cells that play a crucial role in the initiation and maintenance of antitumor immune responses. They recognize, engulf, and process antigens—including those derived from tumor cells—then migrate to lymph nodes where they activate T lymphocytes to induce adaptive immune responses. In cancer, dendritic cell function can be impaired by the suppressive tumor microenvironment, leading to reduced antitumor immunity. Therapeutic strategies such as dendritic cell vaccines aim to restore or enhance DC activation for improved cancer immunotherapy.
Induction of antitumor T cell responses via antigen cross-presentation Maturation and migration to lymph nodes Enhancement of costimulatory signaling
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell (DC) (DC).